{"nct_id":"NCT01466062","title":"Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions","status":"COMPLETED","status_verified_date":"2013-06","start_date":"2011-08","start_date_type":null,"primary_completion_date":"2012-04","primary_completion_date_type":"ACTUAL","completion_date":"2012-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}